Stay updated on ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page.

Latest updates to the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for the study of ADXS11-001 and MEDI4736 is displayed, including study design, participant criteria, outcome measures, and historical results. It also shows that the study is terminated and is no longer recruiting participants.SummaryDifference61%

- Check13 days agoChange DetectedThe ClinicalTrials.gov page footer now shows revision v3.8.0 instead of v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study page content remains a 403 error.SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision changed from v3.7.1 to v3.7.2; the study record remains inaccessible with a 403 Forbidden message.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the study details while the header, navigation, and footer remain visible.SummaryDifference19%

Stay in the know with updates to ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page.